Proteins that specifically inhibit the growth of new blood vessels (ANGIOGENESIS, PHYSIOLOGIC).
More specific conditions that are subtypes of Angiostatic Proteins in the MeSH hierarchy.
4 drugs (1 approved, 3 experimental)